Naltrexone Long Acting Formulations and Methods of Use
AssigneeAlkermes, Inc.
InventorElliot Ehrich
Life of this patent
Estimating the term…
Abstract
The inventions described herein arose from unexpected discoveries made during clinical trials with a long acting formulation of naltrexone. As such, the invention includes a method for treating an individual in need of naltrexone comprising the step of parenterally administering a long acting formulation comprising naltrexone and to the use of naltrexone in the manufacture of medicaments for use in such methods.
Claims12
A method of treating an individual in need of naltrexone comprising administering naltrexone, in the absence of co-administering alcohol, to an individual who has not undergone alcohol abstinence within three days, prior to the naltrexone administration.
A method of increasing the days prior to occurrence of alcohol consumption in an individual in need of naltrexone comprising administering a long acting formulation comprising naltrexone, in the absence of co-administering alcohol, to an individual who has not abstained from alcohol within three days, prior to the naltrexone administration.
Dependencies are inferred from the claim text.